Protagonist Therapeutics (NASDAQ: PTGX) is a clinical-stage biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's revenue model, to the extent supported by its 10-K filed 2026-02-25, is not detailed in the available filing excerpts, and specific product revenues, partnership terms, and financial figures cannot be confirmed from the provided text. The filing identifies the company as listed on The Nasdaq Stock Market LLC under the ticker PTGX. Beyond the company name, exchange listing, and forward-looking statement disclosures typical of a development-stage biopharmaceutical registrant, the excerpts do not supply sufficient detail to characterize revenue streams, competitive position, geographic footprint, leadership, or product pipeline with the specificity required. All further description is omitted to avoid inferring facts not supported by the provided source material.

Source: SEC 10-K, filed 2026-02-25

Industry: Pharmaceutical Preparations Peers: Heron Therapeutics Inc ALX Oncology Holdings Inc Aura Biosciences Inc Organogenesis Holdings Inc bluebird bio, Inc. C4 Therapeutics, Inc Inovio Pharmaceuticals Inc Kodiak Sciences Inc Lexicon Pharmaceuticals Inc